Using this approach, we investigated the effects of KMO inhibition on seizures, depressive-like behaviors, and cognitive function in epileptic mice, thereby providing novel insights and a robust scientific foundation for developing therapeutic strategies targeting epilepsy-associated depression. This evidence concerns the gene KMO and depressive disorder.